Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostacyclin versus heparin as anticoagulant in continuous veno-venous hemodiafiltration
2007-004426-24Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of epoprostenol and heparin in acute kidney failure (AKF) (2 arms), sponsored by Policlinico Gemelli. Primary endpoints: Feasibility and efficacy of prostacyclin versus heparin as anticoagulant in CVVHDF and Effects of prostacyclin on platelets. Started Dec 2007; status: completed.
02
Drugs
epoprostenolheparin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2007-004426-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004426-24.